Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Comput Biol Med ; 135: 104626, 2021 08.
Article in English | MEDLINE | ID: mdl-34246160

ABSTRACT

Bacterial diseases are considered by the World Health Organization to be one of the greatest threats to public health worldwide, mainly due to the increasingly frequent resistance to traditional antibiotics. Estimates from the World Bank indicate that the annual global economic impacts of antibiotic resistance will reach US$1.0-3.4 trillion by 2030. With this, the demand for studies aiming at the discovery of new antibiotics or molecules that may play a synergistic role within the spectrum of drug-resistant bacteria is of fundamental importance. In this in silico study, ligands generated from anthraquinones with established antibacterial activity were evaluated as potential inhibitors of the DNA gyrase subunit B of two species of Gram-positive and two Gram-negative bacteria. The main result of molecular docking-based virtual screening reveals several anthraquinones with remarkable binding energies, of which 7,7'-bializarin (ZINC000004783172) exhibited the highest value for all DNA gyrases subunit B studied and formed stable complexes, as evidenced by molecular dynamics simulations. Collectively, the results presented here reveal the potential of this molecule to bind tightly to the active site of DNA gyrases subunit B of Escherichia coli, Salmonella enterica (subtype typhi), Enterococcus faecalis, and Staphylococcus aureus, and therefore represents a promising candidate for further in vitro testing aimed at evaluating its antibacterial effect.


Subject(s)
DNA Gyrase , Topoisomerase II Inhibitors , Anti-Bacterial Agents/pharmacology , Gram-Negative Bacteria , Gram-Positive Bacteria , Microbial Sensitivity Tests , Molecular Docking Simulation , Topoisomerase II Inhibitors/pharmacology
2.
Buenos Aires; s.n; 2012. 115 p. ilus, tab.
Thesis in Spanish | LILACS, MOSAICO - Integrative health | ID: biblio-911078

ABSTRACT

Ecuador se reconoce desde la Constitución del año 1998 como un país pluricultural y multiétnico y que además está ubicado en uno de los sitios de mayor megabiodiversidad del planeta. Dentro de esa biodiversidad, Viola arguta es una planta endémica del país, que crece en la zona cordillerana, a altitudes de 1500 a 3500 msm, en las provincias de Zamora-Chinchipe, Azuay, Bolívar, Cañar, Carchi, Chimborazo, Cotopaxi, Imbabura, Loja, Morona-Santiago, Pichincha. Conocida como violeta del campo o violeta roja, es utilizada tradicionalmente para el tratamiento de diversas afecciones, entre ellas algunas relacionadas con la capacidad antiinflamatoria que se le atribuye. Hasta donde sabemos, no existen hasta el momento datos botánicos que permitan su reconocimiento, ni información sobre su composición química y actividades biológicas que justifiquen su empleo en terapéutica. A fin de proveer elementos de diagnóstico que contribuyan a su identificación, y eventual control de calidad, así como contribuir a su estudio fitoquímico se encara el análisis micrográfico de esta especie, así como se efectúan los ensayos fitoquímicos preliminares, detección de metabolitos secundarios característicos del género Viola y la determinación de la acción antioxidante y actividad antiinflamatoria.


Subject(s)
Humans , Phytochemicals , Plants, Medicinal , Violaceae , Ecuador
SELECTION OF CITATIONS
SEARCH DETAIL
...